(Q39537795)

12 September 2017

title

Efficacy of nisoldipine combined with beta-adrenergic-blocking drugs in the treatment of chronic stable angina (English)

1 reference

12 September 2017

O'Keefe JC

1

1 reference

12 September 2017

Creamer JE

series ordinal

2

1 reference

12 September 2017

Banim SO

series ordinal

3

1 reference

12 September 2017

language of work or name

1 reference

1 June 1987

1 reference

12 September 2017

1 reference

12 September 2017

volume

10

1 reference

12 September 2017

issue

6

1 reference

12 September 2017

page(s)

345-350

1 reference

The combination of nifedipine and propranolol in the management of patients with angina pectoris

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960100609

Improvement of exercise-induced left ventricular dysfunction with oral propranolol in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960100609

7 January 2021

Long-term propranolol therapy for angina pectoris

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960100609

7 January 2021

Beta-adrenergic receptor blocking drugs. Mechanisms of action and clinical applications

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960100609

7 January 2021

Comparison of high-dose and medium-dose propranolol in the relief of exercise-induced myocardial ischemia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960100609

7 January 2021

Improved exercise tolerance after propranolol, diltiazem or nifedipine in angina pectoris: comparison at 1, 3 and 8 hours and correlation with plasma drug concentration

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960100609

7 January 2021

A double-blind randomized trial of propranolol and verapamil in the treatment of effort angina

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960100609

7 January 2021

Effect of nifedipine on exercise-induced left ventricular dysfunction and myocardial hypoperfusion in stable angina

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960100609

7 January 2021

Comparison of the antianginal effectiveness of nifedipine, verapamil, and isosorbide dinitrate in patients receiving propranolol: a double-blind study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960100609

7 January 2021

Hemodynamic and clinical effects of combined verapamil and propranolol therapy in angina pectoris

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960100609

7 January 2021

Clinical efficacy of verapamil alone and combined with propranolol in treating patients with chronic stable angina pectoris

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960100609

7 January 2021

Objective assessment of antianginal treatment: a double-blind comparison of propranolol, nifedipine, and their combination.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960100609

7 January 2021

Combined acebutolol/nifedipine therapy in patients with chronic coronary artery disease: additional improvement of ischemia-induced left ventricular dysfunction.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960100609

7 January 2021

Comparative electrophysiologic and coronary hemodynamic effects of diltiazem, nisoldipine and verapamil on myocardial tissue

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960100609

7 January 2021

Effect of Nisoldipine upon the General and Coronary Hemodynamics of the Anesthetized Dog

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960100609

7 January 2021

Reassessment of failed beta-blocker treatment in angina pectoris by peak-exercise heart rate measurements

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960100609

7 January 2021

Reproducibility of work performance at serial exercises in patients with angina pectoris

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960100609

7 January 2021

Combined therapy with verapamil and propranolol in chronic stable angina

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960100609

7 January 2021

Therapeutic implications of slow-channel blockade in cardiocirculatory disorders

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960100609

7 January 2021

Identifiers

DOI

10.1002/CLC.4960100609

1 reference

release_hgiv5ius7bdjxosdnmwwheaqga

12 September 2017

Fatcat ID

0 references

1 reference